BioInvest
10x Genomics Reports Second Quarter 2022 Financial Results
Recent Highlights Revenue was $114.6 million for the second quarter, representing a 1% decrease over the corresponding period of 2021. Announ...
August 09, 2022 | News
Catalytic Investment to Improve Community Health Care for Millions Across Africa
Private sector investments to the Global Fund's Africa Frontline First Catalytic Fund from the Johnson & Johnson Foundation and the Skoll Foundation ...
August 09, 2022 | News
Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant
The ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) aims to establish a manufacturing platform for new medical technolog...
August 08, 2022 | News
Q2 2022: Merck Delivers Robust Growth Despite Headwinds
Results of the second quarter of 2022 Group net sales rise by 14.3% to € 5.6 billion All business sectors contribute to strong...
August 04, 2022 | News
Samsung Biologics Reports Second Quarter 2022 Financial Results
Released consolidated financial position of the company based on its full acquisition of Samsung Bioepis completed on April 20, 2022 Achieved recor...
July 28, 2022 | News
Merck Launches its Uptune Program in Asia for Collaborating with Startups
Application period for the Merck Uptune program starts today Topics vary from AI-enabled health and cell and gene therapy tools to innovative te...
July 22, 2022 | News
Merck Launches its Uptune Program in Asia for Collaborating with Startups
Application period for the Merck Uptune program starts today Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologi...
July 15, 2022 | News
Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion
As in prior funds, Fund VIII was oversubscribed and reached its hard cap for limited partner commitments. This increases the firm's capital raised to ...
July 12, 2022 | News
Capnopharm announces asset purchase of Capnomed to continue work on peritoneal cancer
Capnopharm GmbH announced it has entered into an asset purchase agreement to acquire all operating assets from Capnomed GmbH.Founded in 2015, Capnomed ha...
July 11, 2022 | News
BRIM Biotechnology enters OTC trading in Taiwan
Established in July 2013, BRIM is a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative j...
June 24, 2022 | News
Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials
Mojia Biotech, a Shanghai-based leading bio-manufacturing company dedicated to sustainable development and carbon neutrality, announced the completion...
June 23, 2022 | News
Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results
Revenue of $1.61 billion represents 5% reported growth; and up 7% on a core(1) basis. GAAP net income of $274 million with earnings per...
June 21, 2022 | News
Merck Places Bonds Amounting to €1.0 billion
Merck, a leading science and technology company, issued bonds amounting to € 1.0 billion. The revenue from the bond issue will be used for gener...
June 20, 2022 | News
META raised 15M USD to accelerate its pipeline development
META Pharmaceuticals, China's first immunometabolism-based small-molecule drug discovery company, announced two consecutive Seed and Pre-A fundin...
June 14, 2022 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
